Article

A Double-blind, Placebo-controlled Investigation of the Effects of Passiflora incarnata (Passionflower) Herbal Tea on Subjective Sleep Quality

School of Psychology and Psychiatry, Monash University, Clayton, Victoria, Australia.
Phytotherapy Research (Impact Factor: 2.4). 08/2011; 25(8):1153-9. DOI: 10.1002/ptr.3400
Source: PubMed

ABSTRACT Passiflora incarnata is a traditional herbal sedative, anxiolytic and a popular sleep aid used for the treatment of sleep disturbance. Several controlled experiments have demonstrated enhanced sleep in laboratory animals, but clinical trials in humans are lacking. The aim of the present study was to investigate the efficacy of Passiflora incarnata herbal tea on human sleep, as measured using sleep diaries validated by polysomnography (PSG). This study featured a double-blind, placebo-controlled, repeated-measures design with a counterbalanced order of treatments (passionflower vs placebo tea), separated by a 1 week 'washout' period. Forty-one participants (18-35 years) were exposed to each treatment for a week, whereby they consumed a cup of the tea and filled out a sleep diary for 7 days, and completed Spielberger's state-trait anxiety inventory on the seventh morning. Ten participants also underwent overnight PSG on the last night of each treatment period. Of six sleep-diary measures analysed, sleep quality showed a significantly better rating for passionflower compared with placebo (t(40) = 2.70, p < 0.01). These initial findings suggest that the consumption of a low dose of Passiflora incarnata, in the form of tea, yields short-term subjective sleep benefits for healthy adults with mild fluctuations in sleep quality.

Download full-text

Full-text

Available from: Russell Conduit, Dec 03, 2014
13 Followers
 · 
647 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Various species of the genus Passiflora have been extensively used in traditional medicine as sedatives, anxiolytics, diuretics and analgesics. In the present study, after the identification and quantification of phytochemical compounds from yellow passion fruit pulp by liquid chromatography-photodiode array-mass spectrometry (HPLC-PDA-MS/MS), its antihypertensive effect was investigated on spontaneously hypertensive rats. Additionally, the renal function, evaluated by kidney/body weight, serum creatinine, proteinuria, urinary flow, reduced glutathione (GSH) levels and thiobarbituric acid-reactive substances (TBARS) and mutagenicity in bone marrow cells were assessed to evaluate the safety of passion fruit consumption. Yellow passion fruit pulp (5, 6 or 8 g/kg b.w.) was administered by gavage once a day for 5 consecutive days. HLPC-PDA-MS/MS analysis revealed that yellow passion fruit pulp contains phenolic compounds, ascorbic acid, carotenoids and flavonoids. The highest dose of passion fruit pulp significantly reduced the systolic blood pressure, increased the GSH levels and decreased TBARS. There were no changes in renal function parameters or the frequency of micronuclei in bone marrow cells. In conclusion, the antihypertensive effect of yellow passion fruit pulp, at least in part, might be due to the enhancement of the antioxidant status. The exact mechanisms responsible by this effect need further investigation. Copyright © 2013 John Wiley & Sons, Ltd.
    Phytotherapy Research 01/2014; 28(1). DOI:10.1002/ptr.4949 · 2.40 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Introduction. Among pediatric population the sleep disturbances are very common and they can cause cognitive and behavioral impairments. When insomnia is not pathologic, herbal compounds can be used avoiding the side effects of drugs. Aim. Evaluation of a new herbal compound in the treatment of sleep disturbances in a pediatric cohort. Methods. An herbal compound of Eschscholtzia californica and Passiflora incarnata (Vagostabil® Junior) was given to 20 children affected by sleep disorders for 14 consecutive days. Results. The total score of Tayside is improved (p <0.001): from 23.58 ± 5.77 (range 13 - 34) to 14.11 ± 6.72 (range 5 - 32). In particular, children appears to be less reluctant to go to sleep (p <0.001) and fall asleep faster (p <0.001). Also the Brief Infant Sleep Questionnaire scores are significantly reduced: children sleep an extra hour per night (p <0.001), half an hour before going to sleep (p<0.001) than before and during the night awake half the time (p <0.001). Finally, none collateral effects was occurred. Conclusions. The herbal compound of Eschscholtzia californica and Passiflora incarnata (Vagostabil® Junior) can improve significantly the quality of sleep in pediatric patients without contralateral effects.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Research in the area of herbal psychopharmacology has increased markedly over the past decades. To date however, a comprehensive review of herbal antidepressant, anxiolytic and hypnotic psychopharmacology and applications in depression, anxiety and insomnia has been absent. A search of MEDLINE (PubMed), CINAHL, PsycINFO, and the Cochrane Library databases was conducted (up to February 21st 2011) on commonly used psychotropic herbal medicines. A review of the literature was conducted to ascertain mechanisms of action of these botanicals, in addition to a systematic review of controlled clinical trials for treatment of mood, anxiety and sleep disorders, which are common comorbid psychiatric disorders. Specific emphasis was given to emerging phytomedicines. Analysis of evidence levels was conducted, as were effect sizes (Cohen's d) where data were available. Results provided evidence of a range of neurochemical, endocrinological, and epigenetic effects for 21 individual phytomedicines, which are detailed in this paper. Sixty six controlled studies were located involving eleven phytomedicines. Several of these provide a high level of evidence, such as Hypericum perforatum for major depression, and Piper methysticum for anxiety disorders. Several human clinical trials provide preliminary positive evidence of antidepressant effects (Echium amoenum, Crocus sativus, and Rhodiola rosea) and anxiolytic activity (Matricaria recutita, Ginkgo biloba, Passiflora incanata, E. amoenum, and Scutellaria lateriflora). Caution should however be taken when interpreting the results as many studies have not been replicated. Several herbal medicines with in vitro and in vivo evidence are currently unexplored in human studies, and along with use of emerging genetic technologies "herbomics", are areas of potential future research.
    European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology 05/2011; 21(12):841-60. DOI:10.1016/j.euroneuro.2011.04.002 · 5.40 Impact Factor